JW PHARMACEUTICAL
001060 | KO
Overview
Corporate Details
- ISIN(s):
- KR7001060003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 과천시 과천대로7길 38 -, 과천시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 3.1 MB | ||
| 2025-07-31 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-31 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 30.7 KB | ||
| 2025-07-02 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 62.4 KB | ||
| 2025-07-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 103.8 KB | ||
| 2025-06-25 00:00 |
Transaction in Own Shares
자기주식취득결과보고서
|
Korean | 62.4 KB | ||
| 2025-06-13 00:00 |
Legal Proceedings Report
벌금등의부과
|
Korean | 5.9 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 928.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.4 MB | ||
| 2025-05-07 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-04-21 00:00 |
Management Reports
기업가치제고계획(자율공시) (2025년)
|
Korean | 7.5 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 40.6 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 109.2 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 29.5 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.8 KB |
Automate Your Workflow. Get a real-time feed of all JW PHARMACEUTICAL filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for JW PHARMACEUTICAL
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for JW PHARMACEUTICAL via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing novel oral therapies for retinal degenerative eye diseases like GA and Stargardt disease.
United States of America
BLTE
United States of America
BLTE
Develops ddRNAi gene therapies to silence genes causing chronic, life-threatening diseases.
United States of America
BNTC
United States of America
BNTC
Develops innovative and accessible cancer treatments for patients worldwide.
United States of America
ONC
United States of America
ONC
Develops first-in-class AXL kinase inhibitors for cancer and severe respiratory infections.
Norway
BGBIO
Norway
BGBIO
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America
BYSI
United States of America
BYSI
A pharma holding co. making APIs & TCM derivatives via bio-fermentation and extraction.
United States of America
BGM
United States of America
BGM
Developing first-in-class, dual-action bifunctional therapies for solid tumor patients.
United States of America
BCAX
United States of America
BCAX
Developing novel bicyclic peptide medicines to precisely target hard-to-treat cancers.
United States of America
BCYC
United States of America
BCYC
Biotech firm specializing in microbiome R&D for functional foods and cosmeceuticals.
South Korea
238200
South Korea
238200